A phase I-II prospective clinical trial of adjuvant accelerated radiation therapy (ADA-RT-1 trial) was set up in order to investigate the feasibility and efficacy of a pelvic conformal radiotherapy technique with concomitant boost (CB technique) to the vaginal vault in high-risk uterine cancers.
Macchia, G., Ferrandina, M. G., Deodato, F., Bibbò, R., Massaccesi, M., Ippolito, E., Cellini, N., Scambia, G., Valentini, V., Morganti, A. G., 3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1), <<GYNECOLOGIC ONCOLOGY>>, 2011; 120 (3): 485-488. [doi:10.1016/j.ygyno.2010.11.021] [http://hdl.handle.net/10807/14215]
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1)
Macchia, Gabriella;Ferrandina, Maria Gabriella;Deodato, Francesco;Massaccesi, Mariangela;Ippolito, Edy;Cellini, Numa;Scambia, Giovanni;Valentini, Vincenzo;Morganti, Alessio Giuseppe
2011
Abstract
A phase I-II prospective clinical trial of adjuvant accelerated radiation therapy (ADA-RT-1 trial) was set up in order to investigate the feasibility and efficacy of a pelvic conformal radiotherapy technique with concomitant boost (CB technique) to the vaginal vault in high-risk uterine cancers.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
